C7731

カフェイン

meets USP testing specifications, anhydrous

• 別名: 1,3,7-トリメチルキサンチン
• 実験式（ヒル表記法）: C₈H₁₀N₄O₂
• CAS番号: 58-08-2
• 分子量: 194.19
• Beilstein: 17705
• EC Number: 200-362-1
• MDL番号: MFCD00005758
• UNSPSCコード: 12352210
• PubChem Substance ID: 24892984
• NACRES: NA.21

特性

• グレード: anhydrous
• 品質水準: 200
• 認証: USP/NF; meets USP testing specifications
• 形状: crystalline; powder
• mp: 234-236.5 °C (lit.)
• 溶解性: H₂O: soluble 18.7 g/L at 16 °C
• SMILES記法: CN1C(=O)N(C)c2ncn(C)c2C1=O
• InChI: 1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3
• InChI Key: RYYVLZVUVIJVGH-UHFFFAOYSA-N
• 遺伝子情報: human ... ADORA1(134) , ADORA2A(135) , ADORA2B(136) , ADORA3(140) , PDE4B(5142) ; mouse ... Adora2b(11541) ; rat ... Adora1(29290) , Adora2a(25369)

詳細

詳細

Caffeine is a commonly consumed pharmacologically active substance. It is a member of the class of methylxanthines. It is a natural alkaloid found in coffee, cocoa and other plants. Caffeine might be linked to osteoporosis, cardiovascular risk, arrhythmia and gastrointestinal disturbances. Caffeine is used to treat orthostatic hypotension, bronchopulmonary dysplasia and apnea of prematurity (AOP).

アプリケーション

Caffeine has been used:

• to functionally disable Ca²⁺ removal via sarco/endoplasmic reticulum Ca²⁺ ATPase (SERCA)
• to determine its effects in overcoming excitation-contraction-coupling failure
• to compare its role as a stimulant with guarana

安全性情報

• ピクトグラム: GHS07
• シグナルワード: Warning
• 危険有害性情報: H302
• 注意書き: P301 + P312 + P330
• 危険有害性の分類: Acute Tox. 4 Oral
• 保管分類コード: 13 - Non Combustible Solids
• WGK: WGK 1
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable
• 個人用保護具 (PPE): dust mask type N95 (US), Eyeshields, Faceshields, Gloves